Background
Teledermatology (TD) has emerged as a critical way of delivering care remotely in the COVID-19 pandemic.
Objective
We conducted a systematic review to assess how TD has been implemented worldwide.
Methods
We searched PubMed, SCOPUS, EMBASE, Web of Science and Google Scholar for articles on the use of TD for patient care, written in English and published from December 1
st
2019 to October 15
th
2020.
Results
27 studies were included, involving 16,981 patients. There was significant uptake of TD during the pandemic. Synchronous TD appeared to be more commonly implemented than asynchronous TD. Common ambulatory dermatoses such as acne or eczema were reported to be more amenable to TD assessment and management. TD also appeared to be useful for the diagnosis of cutaneous involvement of COVID-19 infection and follow-up of stable onco-dermatology cases.
Limitations
Pooled analysis of all relevant outcomes was not always possible due to the heterogeneity in methodologies of included studies.
Conclusions
TD is a useful and convenient tool for the management of common ambulatory dermatoses in the COVID-19 pandemic.
The characterization of cutaneous squamous cell carcinoma (cSCC) at the molecular level is lacking in the current literature due to the high mutational burden of this disease. Immunosuppressed patients afflicted with cSCC experience considerable morbidity and mortality. In this article, we review the molecular profile of cSCC among the immunosuppressed and immunocompetent populations at the genetic, epigenetic, transcriptomic, and proteometabolomic levels, as well as describing key differences in the tumor immune microenvironment between these two populations. We feature novel biomarkers from the recent literature which may serve as potential targets for therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.